Mid Atlantic Bio Angels (MABA) is a NY-based life science angel investor group, formed in 2012, that invests exclusively in life science science companies, with no geographic limitations.
Because of MABA’s life science focus, the majority of our members are active in the industry:
- Several MABA members are MDs, most of whom are practicing physicians
- Many members are either currently working for, or in the past have worked for a pharmaceutical, biotech or medical device company
- Many members either currently, or in the past, have held C level positions, and many are founders of companies in the life science space
- Several members are attorneys
- Multiple members founded, hold or have held senior positions in private equity, venture capital and hedge funds, while several hold/held CFO positions
- Multiple specialties are featured among the members, including many medical specialties, such as radiation oncology, ophthalmology, toxicology, regulatory (with some members having worked at the FDA), as well as non-medical specialties, such as marketing, finance (several MBAs) and engineering
- Several pharmaceutical and device companies have also joined MABA as members
MABA’s individual members are accredited and active investors with specific interest in life science investments
MABA meetings are held monthly in NYC, with the exception of summer months
MABA investments include individual investments, member-only Pools and a Sidecar Fund – for non-MABA members, that co-invests and essentially indexes the active membership’s investments
MABA individuals/Pools/Sidecar Fund typically invest between $250,000 and $1 million per round, in early rounds, and participate in follow-on rounds
MABA typically invests in 2% of the applications it receives